Aethlon Medical, Inc., a San Diego-based medical technology firm, is on a mission to create innovative products that can help diagnose and treat life-threatening diseases. Their flagship product, the Aethlon Hemopurifier, is a clinical-stage immunotherapy device designed to remove tumor-derived exosomes and viruses that pose a risk to human lives and organs from the circulatory system. Specifically, the product is capable of removing COVID-19 virus, associated variants, and associated exosomes. The company has also partnered with the University of Pittsburgh Medical Center Hillman Cancer Center for research relating to head and neck cancer. Founded in 1999, Aethlon Medical, Inc. is at the forefront of medical technology and is committed to creating products that can help save lives.